Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience

Item

http://www.wikidata.org/entity/Q35812684

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Familial screening and genetic ...... athy: the Rotterdam experience

@ast

Familial screening and genetic ...... athy: the Rotterdam experience

@en

type

Item

label

Familial screening and genetic ...... athy: the Rotterdam experience

@ast

Familial screening and genetic ...... athy: the Rotterdam experience

@en

prefLabel

Familial screening and genetic ...... athy: the Rotterdam experience

@ast

Familial screening and genetic ...... athy: the Rotterdam experience

@en

P1476

Familial screening and genetic ...... athy: the Rotterdam experience

@en

P2093

Dooijes D

http://www.w3.org/2001/XMLSchema#string

Frohn-Mulder I

http://www.w3.org/2001/XMLSchema#string

Hoedemaekers YM

http://www.w3.org/2001/XMLSchema#string

Kofflard MJ

http://www.w3.org/2001/XMLSchema#string

Majoor-Krakauer D

http://www.w3.org/2001/XMLSchema#string

Michels M

http://www.w3.org/2001/XMLSchema#string

Ten Cate FJ

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and F

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration.

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.

Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.

P2888

bf03085978

P304

184-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03085978

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17612681

http://www.w3.org/2001/XMLSchema#string

P932

1877969

http://www.w3.org/2001/XMLSchema#string